Searchable abstracts of presentations at key conferences in endocrinology

ea0056oc14.5 | What is new in gestational and type 1 diabetes? | ECE2018

Type 1 diabetes mellitus: defining the best cut-off points of arterial stiffness for predicting cardiovascular risk according to the Steno Type 1 Risk Engine

Cano Albert , Llaurado Gemma , Fabregas Lara Albert , Mazarico Isabel , Gonzalez-Sastre Montserrat , Gonzalez-Clemente Jose Miguel

Background: Cardiovascular disease (CVD) is the leading cause of death in persons with type 1 diabetes (T1DM). However, there are no CVD-risk prediction models for this population in widespread use and those developed from general population and type 2 diabetes have been shown to underestimate CVD-risk in T1DM. Recently, the Steno Type 1 Risk Engine (ST1RE) was developed for predicting CVD in a cohort of T1DM persons without clinical CVD. We investigate the relationship betwee...

ea0081ep284 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Factors affecting glycemic outcomes using closed-loop systems in real-world

Fabregas Lara Albert , Andujar David Subias , Gregori Ana Romero , Luchtenberg Maria Florencia , Palomares Albert Cano , Mazarico Isabel , Rigla Mercedes

Aims: To evaluate real-world efficacy of closed-loop systems (CLS) (MinimedTM 780G, DBLG1 -Diabeloop- and Control-IQTM Tandem) as well as to assess those predictive factors related with the achievement of near-normal glycemic control.Methods: A prospective, longitudinal, and observational study was performed. It included T1D adults who initiated CLS between April and December 2021 in our hospital and provided data for ≧3 months (...

ea0063p39 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

A novel CYP11B1 mutation presenting as a classical congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency

Mazarico Isabel , Gimenez-Palop Olga , Albert Lara , Florencia Luchtenberg , Casamitjana Laia , Capel Ismael , Subias David , Cano Albert , Guitart Miriam , Caixas Assumpta , Rigla Mercedes

Background: Congenital adrenal hyperplasia (CAH) is a rare autosomal recessive disorder, of which 21-hydroxylase deficiency (21OHD) is the most frequent form. 11 beta-hydroxylase deficiency (11bOHD) is the second most common type of CAH. This pathology results from inactivating mutations in CYP11B1 gene.Case presentation: We describe a case of a 48-year-old woman with 11bOHD, presented with hypokalemia hypertension, early adrenarche and mild vir...

ea0049gp238 | Thyroid Cancer & Thyroid Case Reports | ECE2017

A fatal case of fetal goiter: autoimmunity is the key

Berges-Raso Irene , Albert Lara , Caixas Assumpta , Capel Ismael , Cano Albert , Mazarico Isabel , Serra Laura , Corona Manuel , Martinez Cesar Martin , Rigla Mercedes

Introduction: Fetal goiter is an infrequent and potentially life-threating condition derived from either fetal hypothyroidism or hyperthyroidism. TSH-receptor stimulating antibodies (TSH-R-ABs) can cross the placenta and induce fetal hyperthyroidism and goiter. We describe a rare case of TSH-R-ABs-induced hyperthyroidism in a woman with autoimmune hypothyroidism (AH) without previous hyperthyroidism.Case Report: A 28 years old pregnant woman under treatm...

ea0049ep165 | Endocrine tumours and neoplasia | ECE2017

Could alcohol ablation become the standard of care for benign insulinomas?

Mazarico Isabel , Subias David , Junquera Felix , Vilardell Carme , Saigi Ignasi , Cano Albert , Casamitjana Laia , Gimenez-Palop Olga , Albert Lara , Capel Ismael , Caixas Assumpta , Rigla Mercedes

Introduction: Surgical resection is currently considered the standard treatment for symptomatic insulinomas; however, its morbidity is high (>10%) and it is restricted to suitable candidates. In recent years, alternative minimally invasive therapies, such as endoscopic ultrasound (EUS)-guided ethanol ablation (EA), have emerged as new therapeutic options, especially for small lesions or poor surgical candidates. We report two cases of insulinoma ablated with EA.<p clas...

ea0049ep641 | Neuroendocrinology | ECE2017

Comparison of GHRH + arginine vs glucagon test for the evaluation of growth hormone secretion status in a cohort of adults with Prader-Willi syndrome (PWS)

Casamitjana Laia , Olga Gimenez-Palop , Raquel Corripio , Rocio Pareja , Marta Hurtado , Elisabet Gabau , Jesus Cobo , Eugenio Berlanga , Albert Cano , Lara Albert , Mercedes Rigla , Assumpta Caixas

Background: Prader-Willi syndrome (PWS) is a rare genetic disorder evolving morbid obesity and growth hormone deficiency (GHD). Testing GH-IGF1 axis is required before treatment with rhGH in adults with PWS (1). The most common used tests in these patients are GHRH+arginine (GHRH+a) and insulin tolerance test. There are no prospective data for glucagon test (GT) in comparison to GHRH+a in adults with PWS. Mechanism by which GT causes GH release remains unclear, glucagon-induce...

ea0041ep799 | Obesity | ECE2016

16p11.2 Microdeletion and Prader Willi syndrome: similarities and differences

Casamitjana Laia , Caixas Assumpta , Berges Irene-Noelia , Albert Lara , Cano Albert , Capel Ismael , Gimenez-Palop Olga , Gabau Elisabet , Corripio Raquel , Rigla Mercedes

Introduction: Prader Willi syndrome (PWS) is the most common syndromic form of obesity, caused by the absence of expression of the paternally active gens on the long arm of chromosome 15.The 16p11.2 microdeletion has recently been recognized as a syndromic condition appearing to be a predisposing factor for overweight, being the second most common genetic cause of obesity. One possible causative gen- SH2B1- involving leptin and insulin signaling, has been identified, although ...

ea0056p27 | Adrenal cortex (to include Cushing's) | ECE2018

A new ARMC5 mutation responsible for primary bilateral macronodular adrenal hyperplasia

Mazarico Isabel , Subias David , Guitart Miriam , Bella Rosa Maria , Albert Lara , Luchtenberg Florencia , Berges Irene , Capel Ismael , Cano Albert , Casamitjana Laia , Gimenez-Palop Olga , Caixas Assumpta , Rigla Mercedes

Introduction: Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause (<2 percent) of endogenous Cushing’s syndrome, usually characterized by enlarged adrenal glands containing multiple functioning nonpigmented macronodules. PBMAH was thought to be sporadic, but recently a genetic component has been described. Specifically, inactivating mutations in ARMC5 (Armadillo-repeat containing 5), a suppressor gene, have been found in many familial c...

ea0056p391 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Stiff - person syndrome in an old woman with late onset type 1 diabetes mellitus

Luchtenberg Maria Florencia , Capel Ismael , Mazarico Isabel , Cano Albert , Albert Lara , Casamitjana Laia , Subias David , Martinez Jose Miguel , Caixas Assumpta , Rigla Mercedes

Introduction: Stiff person syndrome (SPS) is a rare neurological disease resulting in stiffness and spasm of muscles and, as a consequence, severely impaired ambulation. Pathophysiology of the disease is based on an increased muscle activity caused by the decreased level of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) due to an autoimmune attack against glutamic acid decarboxylase (GAD); enzyme which is also one of the main autoantigens of type 1 diabetes mel...